Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Preparation for treatment and
prophylaxis of infections caused by flaviviruses,
primarily by tick-borne
encephalitis virus.


詳細技術說明

Flaviviral infections represent a significant global health risk and can severely damage the central nervous system. Vaccines are available for some of the flaviviruses, but only a small part of the population is vaccinated, mostly due to the vaccines` prices. Furthermore, effective antivirotics against most of the flaviviral infections are not available. In the case of tick-borne encephalitis, only supportive treatment is available; interferons (a group of cytokines) can be used in severe infections. One of the options for treatment of flaviviral infections could be the plant-derived molecules stilbenes, primarily resveratrol and its analogues, such as its glycated form piceid and its oligomer viniferin. One of the drawbacks of the use of stilbenes is that it does not show satisfactory results in prophylaxis and treatment of flaviviral infections.This utility model shows the use of a combination of stilbenes with interferon for treatment and prophylaxis of infections caused by the tick-borne encephalitis virus. Antiviral effects were shown for a combination of interferons with all three tested stilbenes – resveratrol, piceid, and viniferin.


申請日期

06/03/2018 00:00:00


ID號碼

31559


國家/地區

捷克共和國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版